SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053234
Filing Date
2020-11-12
Accepted
2020-11-12 06:41:55
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mtcr-10q_20200930.htm 10-Q 2475992
2 EX-31.1 mtcr-ex311_8.htm EX-31.1 19002
3 EX-31.2 mtcr-ex312_6.htm EX-31.2 18026
4 EX-32.1 mtcr-ex321_7.htm EX-32.1 14168
  Complete submission text file 0001564590-20-053234.txt   7821088

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtcr-20200930.xml EX-101.INS 1687938
6 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20200930.xsd EX-101.SCH 49161
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtcr-20200930_cal.xml EX-101.CAL 47057
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtcr-20200930_def.xml EX-101.DEF 137837
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20200930_lab.xml EX-101.LAB 422496
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20200930_pre.xml EX-101.PRE 297789
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39512 | Film No.: 201303215
SIC: 2834 Pharmaceutical Preparations